Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
23.03
+1.24 (5.69%)
At close: May 6, 2026, 4:00 PM EDT
21.84
-1.19 (-5.17%)
After-hours: May 6, 2026, 7:55 PM EDT
Sarepta Therapeutics Employees
Sarepta Therapeutics had 835 employees as of December 31, 2025. The number of employees decreased by 537 or -39.14% compared to the previous year.
Employees
835
Change (1Y)
-537
Growth (1Y)
-39.14%
Revenue / Employee
$2,615,789
Profits / Employee
$77,913
Market Cap
2.43B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 835 | -537 | -39.14% |
| Dec 31, 2024 | 1,372 | 58 | 4.41% |
| Dec 31, 2023 | 1,314 | 152 | 13.08% |
| Dec 31, 2022 | 1,162 | 322 | 38.33% |
| Dec 31, 2021 | 840 | -26 | -3.00% |
| Dec 31, 2020 | 866 | 123 | 16.55% |
| Dec 31, 2019 | 743 | 244 | 48.90% |
| Dec 31, 2018 | 499 | 244 | 95.69% |
| Dec 31, 2017 | 255 | 58 | 29.44% |
| Dec 31, 2016 | 197 | -73 | -27.04% |
| Dec 31, 2015 | 270 | 66 | 32.35% |
| Dec 31, 2014 | 204 | 58 | 39.73% |
| Dec 31, 2013 | 146 | 43 | 41.75% |
| Dec 31, 2012 | 103 | 5 | 5.10% |
| Dec 31, 2011 | 98 | 0 | - |
| Dec 31, 2010 | 98 | 35 | 55.56% |
| Dec 31, 2009 | 63 | -20 | -24.10% |
| Dec 31, 2008 | 83 | -42 | -33.60% |
| Dec 31, 2007 | 125 | 8 | 6.84% |
| Dec 31, 2006 | 117 | -6 | -4.88% |
| Dec 31, 2005 | 123 | 11 | 9.82% |
| Dec 31, 2004 | 112 | 6 | 5.66% |
| Dec 31, 2003 | 106 | 17 | 19.10% |
| Dec 31, 2002 | 89 | 4 | 4.71% |
| Dec 31, 2001 | 85 | 14 | 19.72% |
| Dec 31, 2000 | 71 | 15 | 26.79% |
| Dec 31, 1999 | 56 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| ADMA Biologics | 647 |
| Vera Therapeutics | 249 |
| Relay Therapeutics | 192 |
| Immunome | 177 |
| Disc Medicine | 155 |
| IDEAYA Biosciences | 145 |
SRPT News
- 3 hours ago - Sarepta Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 4 hours ago - Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments - Business Wire
- 14 days ago - Sarepta Therapeutics to Announce First Quarter 2026 Financial Results - Business Wire
- 5 weeks ago - Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Why Is Sarepta Therapeutics Stock Exploding Today? - Benzinga
- 6 weeks ago - Sarepta Therapeutics Transcript: Study result - Transcripts
- 6 weeks ago - Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 - Business Wire
- 6 weeks ago - Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 - Business Wire